Dr. James A. Hayward has served as Chief Executive Officer since March 2006, and was President from March 2006 to December 2024. Hayward joined the Company as acting Chief Executive Officer in October 2005, was promoted to President and Chief Executive in March 2006, and was later appointed to Chairman of the Board of Directors in June 2007.
Dr. Hayward has over 40 years of experience in the biotechnology, pharmaceutical, life science and consumer product industries. He was one of the founding principals and Research Director at Biocompatibles Ltd., Europe’s first liposome company. From 1984 to 1989, he was responsible for product development at Estée Lauder Companies, where he served as worldwide director of research.
From 1990 to July 2004, He was the Chairman, President, and CEO of The Collaborative Group, Ltd., a provider of products and services to the biotechnology, pharmaceutical and consumer-product industries based in Stony Brook, New York.
Since 2000, Dr. Hayward has been a General Partner of Double D Venture Fund, a venture capital firm based in New York, New York. He also serves on the boards of the Stony Brook Foundation, the Research Foundation of the State of New York, Long Island Life Sciences Initiative and the Ward Melville Heritage Foundation.
Dr. Hayward received his bachelor’s degree in biology and chemistry from the State University of New York at Oneonta in 1976, his Ph.D. in Molecular Biology and Biophysics from the State University of New York at Stony Brook in 1983, and an honorary Doctor of Science from the State University of New York at Stony Brook in 2000.
